Literature DB >> 2848897

Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

G J Demmler1, G J Buffone, C M Schimbor, R A May.   

Abstract

Polymerase chain reaction (PCR) amplification was used to detect cytomegalovirus (CMV) in tissue culture and in urine specimens from newborns. Synthetic oligonucleotide primer pairs were used to amplify DNA from the major immediate-early and the late antigen genes of CMV. Amplified products were detected by gel electrophoresis and by dot-blot hybridization with oligonucleotide probes. Using one or both of the primer pairs and associated probes, we found 46 different tissue culture isolates of CMV that were positive; no reaction products were detected when the same primers and probes were used to amplify other herpes family viruses or human genomic DNA. Urine samples from 44 congenitally infected infants were positive when tested with one or both primer pairs and probes. When compared with tissue culture, detection by gel electrophoresis provided a sensitivity of 93%, a specificity of 100%, and a predictive value of a positive result of 100%. Dot-blot analysis raised the sensitivity to 100%. We conclude that PCR amplification may be a valuable tool for diagnosing congenital CMV infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848897     DOI: 10.1093/infdis/158.6.1177

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  97 in total

1.  Time-resolved fluorometry PCR assay for rapid detection of herpes simplex virus in cerebrospinal fluid.

Authors:  V Hukkanen; T Rehn; R Kajander; M Sjöroos; M Waris
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Development of a quadriplex polymerase chain reaction for human cytomegalovirus detection.

Authors:  P Markoulatos; V Samara; N Siafakas; E Plakokefalos; N Spyrou; M L Moncany
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 3.  Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus.

Authors:  Sheila C Dollard; Mark R Schleiss; Scott D Grosse
Journal:  J Inherit Metab Dis       Date:  2010-06-08       Impact factor: 4.982

4.  Evaluation of enzyme-linked immunosorbent assays and a PCR test for detection of shiga toxins for shiga toxin-producing Escherichia coli in cattle herds.

Authors:  Monserrat Segura-Alvarez; Heinz Richter; Franz J Conraths; Lutz Geue
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  Evidence of human herpesvirus 6 in Sjögren syndrome and sarcoidosis.

Authors:  A M Fillet; G Raguin; H Agut; S Boisnic; S Agbo-Godeau; C Robert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

6.  Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region.

Authors:  S Chou
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

7.  Increase in severity of graft versus host disease by cytomegalovirus.

Authors:  A L McCarthy; J S Malik Peiris; C E Taylor; M A Green; L Sviland; A D Pearson; A J Malcolm
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

8.  Rapid epidemiologic analysis of cytomegalovirus by using polymerase chain reaction amplification of the L-S junction region.

Authors:  D M Sokol; G J Demmler; G J Buffone
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

9.  Comparison of rapid methods of detection of cytomegalovirus in saliva with virus isolation in tissue culture.

Authors:  W P Warren; K Balcarek; R Smith; R F Pass
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

10.  Detection of cytomegalovirus in urine samples by an enzyme-linked immunosorbent assay using a monoclonal antibody against the viral 150-kilodalton protein.

Authors:  T Yamanaka; K Kiyotani; T Sakaguchi; Y Fukuda; K Dohi; M Yamada; M Yoshida; S Nii; T Yoshida
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.